Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sirolimus Shizuoka 2019-1 safety study in Japanese patients with FCD-related epilepsy
jRCTs041190059Completed
- Sponsor
- Japan Agency for Medical Research and Development
- Start
- Aug 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of sirolimus in epilepsy, sponsored by Japan Agency for Medical Research and Development. Primary endpoint: Adverse events. Started Aug 2019; status: completed.
02
Drugs
sirolimus
03
Conditions
epilepsy
Beyond the preview
Go deeper on jRCTs041190059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041190059.